SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $451,674 | -30.9% | 9,606 | -44.0% | 0.13% | -51.7% |
| Q4 2022 | $654,025 | +17.0% | 17,148 | -0.9% | 0.26% | -5.7% |
| Q2 2022 | $559,000 | +162.4% | 17,298 | +168.8% | 0.28% | +134.5% |
| Q1 2022 | $213,000 | -27.1% | 6,435 | -2.5% | 0.12% | -35.3% |
| Q3 2021 | $292,000 | -17.7% | 6,597 | -46.6% | 0.18% | -78.1% |
| Q1 2020 | $355,000 | +7.3% | 12,359 | +583.6% | 0.84% | +282.3% |
| Q2 2019 | $331,000 | +22.1% | 1,808 | -46.8% | 0.22% | +134.0% |
| Q2 2017 | $271,000 | – | 3,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |